The combination of these markers with NfL suggests the interpretation ability of a diagnostic marker panel is enhanced and offers a more distinctive ability to distinguish fast progressors compared to rarer forms of ALS [66]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.